Tickerplace logo

Tickerplace

Neuphoria Therapeutics Inc. logo

NEUPNeuphoria Therapeutics Inc.

NEUP Stock Price, Valuation & Chart | Neuphoria Therapeutics Inc.

Compare
$3.300-0.01 (-0.30%)

At close · 16 Oct 2026, 08:00 pm

Sector: HealthcareIndustry: Medical - Pharmaceuticals
OverviewFinancialsDividendsRatios

NEUP Historical price chart

NEUP Key Stats

Market Capitalization17.86M
PE Ratio-0.3
EPS-11.06
Trading Volume73.05K
Today's High/Low3.41/3.24
Dividend Yield0.00
52 Week High/Low17.19/3.19
Shares Outstanding5.41M
NEUP Financial Statement
NEUP Analyst ratings
NEUP Analysis & performance metrics

NEUP Company profile

Neuphoria Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by…

NEUP Management team

Management
Rajeev Chandra B.Com., C.A., M.B.A.
Company Secretary
Adrian Hinton BEC, F.C.A.
Financial Controller
Spyridon Papapetropoulos M.D., Ph.D.CEO
Chief Executive Officer, President & Director
Mark A. Smith M.D., Ph.D.
Chief Medical Officer
Julie Kerner Ph.D.
Senior Vice President of Business Operations
Elizabeth Doolin
Senior Vice President of Clinical Development
Total 6 executives

NEUP Frequently asked questions

What is Neuphoria Therapeutics Inc. (NEUP) Stock Price?

Current stock price of Neuphoria Therapeutics Inc. (NEUP) stock is $3.300. The stock price is -0.30% lower in the session. The intraday range can be seen from this page. Volume of Neuphoria Therapeutics Inc. (NEUP) stock is 73.05K.

Last updated at 16 Oct 2026, 08:00 pm.

Why is the Neuphoria Therapeutics Inc. (NEUP) stock price going up or down today?

The stock price of Neuphoria Therapeutics Inc. (NEUP) can change with earnings, company news, and overall market sentiment. Neuphoria Therapeutics Inc. operates in the Healthcare / Medical - Pharmaceuticals market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Neuphoria Therapeutics Inc. stock expensive at its current price?

Whether Neuphoria Therapeutics Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for NEUP on this page is -0.30. EPS on this page is -11.06. Compare those figures with peers and growth expectations before deciding if the current Neuphoria Therapeutics Inc. price is justified.

How has the stock price of Neuphoria Therapeutics Inc. (NEUP) performed historically?

Historical performance for Neuphoria Therapeutics Inc. (NEUP) is shown on the price chart on this page. Review multi-period moves alongside volume to see how NEUP reacted to past earnings and market events.

Should I buy Neuphoria Therapeutics Inc. (NEUP) stock, at this price?

Buying Neuphoria Therapeutics Inc. (NEUP) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.